Search details
1.
Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study.
Int J Clin Oncol
; 29(4): 386-397, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38381163
2.
Ocular toxicity of investigational anti-cancer drugs in early phase clinical trials.
Invest New Drugs
; 41(1): 173-181, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36471215
3.
Correlation of toxicities and efficacies of pemetrexed with clinical factors and single-nucleotide polymorphisms: a prospective observational study.
BMC Cancer
; 23(1): 800, 2023 Aug 26.
Article
in English
| MEDLINE | ID: mdl-37633908
4.
Practical consideration for successful sequential tumor biopsies in first-in-human trials.
Invest New Drugs
; 40(4): 841-849, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35404018
5.
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV.
Int J Clin Oncol
; 24(7): 731-770, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31049758
6.
Tumour-to-tumour metastasis from papillary thyroid carcinoma with BRAF mutation to lung adenocarcinoma with EGFR mutation: the utility of mutation-specific antibodies.
Histopathology
; 67(2): 262-6, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25556681
7.
Safety, tolerability, pharmacokinetics, and antitumor activity of adavosertib in Japanese patients with advanced solid tumors: A phase I, open-label study.
Cancer Treat Res Commun
; 39: 100809, 2024.
Article
in English
| MEDLINE | ID: mdl-38593512
8.
Travel Time and Distance and Participation in Precision Oncology Trials at the National Cancer Center Hospital.
JAMA Netw Open
; 6(9): e2333188, 2023 09 05.
Article
in English
| MEDLINE | ID: mdl-37713200
9.
Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian Patients.
Cancer Res Commun
; 3(11): 2302-2311, 2023 11 14.
Article
in English
| MEDLINE | ID: mdl-37916805
10.
Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors.
JTO Clin Res Rep
; 4(10): 100573, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37799325
11.
Phase Ib/II Study of a Liposomal Formulation of Eribulin (E7389-LF) plus Nivolumab in Patients with Advanced Solid Tumors: Results from Phase Ib.
Cancer Res Commun
; 3(7): 1189-1199, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37435605
12.
Emerging PD-1/PD-L1 targeting immunotherapy in non-small cell lung cancer: Current status and future perspective in Japan, US, EU, and China.
Front Oncol
; 12: 925938, 2022.
Article
in English
| MEDLINE | ID: mdl-36091105
13.
Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma.
Front Oncol
; 12: 966527, 2022.
Article
in English
| MEDLINE | ID: mdl-36698400
14.
Comparison of the Efficacy of EGFR Tyrosine Kinase Inhibitors Erlotinib and Low-dose Osimertinib on a PC-9-GFP EGFR Mutant Non-small-cell Lung Cancer Growing in the Brain of Nude Mice.
In Vivo
; 34(3): 1027-1030, 2020.
Article
in English
| MEDLINE | ID: mdl-32354888
15.
Current and future trends in whole genome sequencing in cancer.
Cancer Biol Med
; 21(1)2024 02 15.
Article
in English
| MEDLINE | ID: mdl-38356245
16.
Rapid temporal improvement of pembrolizumab-induced pneumonitis using the anti-TNF-α antibody infliximab.
Drug Discov Ther
; 13(3): 164-167, 2019 Jul 22.
Article
in English
| MEDLINE | ID: mdl-31257354
17.
Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study.
Eur J Cancer
; 113: 78-86, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30991261
18.
Osimertinib Regresses an EGFR-Mutant Cisplatinum- Resistant Lung Adenocarcinoma Growing in the Brain in Nude Mice.
Transl Oncol
; 12(4): 640-645, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30807997
19.
Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model.
Anticancer Res
; 39(9): 4667-4671, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-31519565
20.
The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft model.
Biomed Pharmacother
; 117: 109093, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-31200257